Edition:
United Kingdom

Idera Pharmaceuticals Inc (IDRA.OQ)

IDRA.OQ on NASDAQ Stock Exchange Capital Market

8.50USD
9:00pm BST
Change (% chg)

$-0.17 (-1.96%)
Prev Close
$8.67
Open
$8.63
Day's High
$8.77
Day's Low
$8.20
Volume
35,073
Avg. Vol
112,341
52-wk High
$20.40
52-wk Low
$5.22

Chart for

About

Idera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutics for oncology and rare diseases. The Company utilizes two drug discovery technology platforms to design and develop drug candidates, which include Toll-like receptor (TLR) targeting... (more)

Overall

Beta: 2.14
Market Cap(Mil.): $363.61
Shares Outstanding(Mil.): 149.63
Dividend: --
Yield (%): --

Financials

  IDRA.OQ Industry Sector
P/E (TTM): -- 85.83 33.69
EPS (TTM): -0.35 -- --
ROI: -70.35 0.58 14.30
ROE: -71.53 1.62 16.03

BRIEF-Idera Pharmaceuticals Reports Q1 Loss Per Share $0.10

* IDERA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

09 May 2018

Earnings vs. Estimates